Anew Bare Acne Clearing Treatment 2% Salicylic Acid

Manufacturer
THE AVON COMPANY | Cosmax Usa, Corporation
Effective date
2026-04-02
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-06-03 18:03:38

Label at a glance#

ProductAnew Bare Acne Clearing Treatment 2% Salicylic Acid
Active ingredientSALICYLIC ACID
Label structure9 sections

Indications and uses

• Clears acne blemishes and allows skin to heal • Helps prevent new acne blemishes from forming

Dosage and administration

Cleanse skin thoroughly before applying this product. Cover the affected area entirely up to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed, or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

Purpose

OTC - PURPOSE SECTION

Acne Treatment

Uses

INDICATIONS & USAGE SECTION

• Clears acne blemishes and allows skin to heal
• Helps prevent new acne blemishes from forming

Warnings

WARNINGS SECTION

  • For external use only.

When using

OTC - WHEN USING SECTION

When using this product skin irritation and dryness are more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • Keep out of reach of children.

DOSAGE & ADMINISTRATION SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

INSTRUCTIONS FOR USE SECTION

  • Cleanse skin thoroughly before applying this product.
  • Cover the affected area entirely up to three times daily.
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed, or as directed by a doctor.
  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Other Information

SPL UNCLASSIFIED SECTION

Protect the product in this container from excessive moisture and heat.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

WATER, BUTYLENE GLYCOL, GLYCERIN, PENTYLENE GLYCOL, NIACINAMIDE, POLYGLYCERYL-4 CAPRATE, POLYGLYCERYL-6 CAPRYLATE, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER, SODIUM HYDROXIDE, 1,2-HEXANEDIOL, CAPRYLYL GLYCOL, ALLANTOIN, BISABOLOL, PANTHENOL, SODIUM HYALURONATE, POLYSORBATE 60, SORBITAN ISOSTEARATE, SODIUM PHYTATE, SODIUM CARBONATE, CAMELLIA SINENSIS LEAF EXTRACT, SALIX ALBA (WILLOW) BARK EXTRACT, SIMMONDSIA CHINENSIS (JOJOBA) SEED EXTRACT, TROPOLONE.

Questions?

OTC - QUESTIONS SECTION

1-800-FOR-AVON

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CartonCartonBottleBottle

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 26 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10096-293210096-2932-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 25 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Anew Bare Acne Clearing Treatment 2% Salicylic AcidSALICYLIC ACIDTHE AVON COMPANY4e7d1429-0498-5812-e063-6394a90a4d4d2026-04-02WarningsExact identifier
ndc (package): 10096-2932-1
ndc (product): 10096-2932
ndc11 (package): 10096293201
spl id: 4e7d1436-663c-80fb-e063-6294a90af430
spl set id: 4e7d1429-0498-5812-e063-6394a90a4d4d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.